Skip to search formSkip to main contentSkip to account menu

Recombinant Interleukin-5

Known as: BCGF-II, Eosinophil Differentiation Factor, IL-5 
A recombinant therapeutic agent which is chemically identical to or similar to the endogenous cytokine interleukin-5 (IL-5). Produced by T cells, IL… 
National Institutes of Health

Related topics

Related topics

5 relations
IL5 geneInhibition of Cell ProliferationInterleukin-5interleukin-5 binding activity

Narrower (1)

IL5 protein, human

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
[IL-5 AND ALLERGIC INFLAMMATION].
Review
2015
Review
2015
Monoclonal antibodies in pediatric allergy
Production of monoclonal antibodies (mAbs) involving human-mouse hybrid cells was first described in 1970s, but these biologics… 
2009
2009
Useful recombinant il-5 antagonists in the treatment of diseases mediated by il-5
Highly Cited
2008
Highly Cited
2008
Sensitive human interleukin 5 impedimetric sensor based on polypyrrole-pyrrolepropylic acid-gold nanocomposite.
A sensitive impedimetric immunosensor was constructed by using an electropolymerized nanocomposite film containing polypyrrole… 
2007
2007
Effect of recombinant interleukin-5, interleukin-3, and eotaxin on apoptosis in eosinophilic granulocytes
We studied in vitro effects of recombinant interleukin-5, interleukin-3, and eotaxin on programmed death of eosinophils from… 
1998
1998
Expression of rat interleukin-5 and generation of neutralizing antiserum: a comparative study of rat IL-5 produced in Escherichia coli and insect cells.
A cDNA coding for rat IL-5 was obtained by RT-PCR from total spleen RNA. With the exception of a single a.a. replacement at… 
1995
1995
Abolition of suppressive effect of acute myeloid leukemia cells on normal granulocyte-macrophage colony formation induced by interleukin-5 associated with eosinophilic cell induction.
The effects of recombinant interleukin-5 (rIL-5) on leukemic blasts obtained from 22 acute myeloid leukemia (AML) patients were… 
1994
1994
TNF alpha-induced activation of eosinophil oxidative metabolism and morphology--comparison with IL-5.
Human dermal mast cells are capable of releasing cytokines, particularly preformed TNF alpha, upon appropriate stimulation. Mast… 
1992
1992
Effect of human recombinant interleukin‐5 on in vitro responsiveness to PAF of lung from actively sensitized guinea‐pigs
1 The intra‐tracheal (i.t.) administration of human recombinant interleukin‐5 (rhIL‐5; 100 or 300 ng) to isolated perfused lungs… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)